Dr. Chandler Park M.D., F.A.C.P.
Dr. Chandler Park is a board certified medical physician specializing in medical oncology and hematology. He is a practicing physician and a volunteer clinical professor at the University of Louisville School of Medicine.
Dr. Park was inducted into the Class of 2016 Fellowship of American College of Physicians (FACP) and recognized by his physician peers in Washington D.C. at the annual American College of Physicians meeting for providing outstanding patient care and significant cancer research contributions to the field of medicine. Dr. Park is also the founder of Cancervisit® and CancerVisit.com to help cancer patients and their families.
He has also served as an assistant professor, attending hospitalist physician, and Chief Resident at Indiana University Health affiliated hospitals. He is an accomplished medical researcher having written many scientific research articles and manuscripts in leading medical journals.
His cancer research has been presented at leading cancer society meetings including his research on PET/CT and regional brain metabolic changes associated with depression in breast cancer patients at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting.
His research group also pioneered the use of pressure relieving viscoelastic pads on MRI tables to improve patient care. He has completed a Hematology and Medical Oncology Fellowship at West Virginia University and received additional physician fellowship training in Cancer Immunotherapy to help melanoma, lung cancer, and genitourinary cancer patients at the University of Pittsburgh Cancer Institute.
Dr. Park served his transitional internship at Cleveland Clinic Foundation Health System and diagnostic radiology and medical residencies at Indiana University Health affiliated hospitals. He earned his undergraduate degree in Biomedical Engineering from the University of Illinois at Urbana-Champaign and his Masters Degree in Biophysics and Medical Doctorate from the University of Louisville School of Medicine.